InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: RRdog post# 82724

Tuesday, 07/10/2012 11:57:35 PM

Tuesday, July 10, 2012 11:57:35 PM

Post# of 346159
RRdog, I am very much looking forward to how this plays out.
Last month there were two papers in the NEJM about the antibodies
against PD-1 and PD-L1. There were a lot of articles written about it.
See my posts # 80964, 80971, 80981, 82402. I think that bavituximab
will be shown to be far superior to the two antibodies in the NEJM papers.
This appeared yesterday and also goes on about the same antibodies.
From the July 10, 2012 issue of Cancer Cell
The Future of Cancer Treatment: Will It Include Immunotherapy?
Jeffrey A. Bluestone1,2,* and Eric J. Small2
1Diabetes Center
2Department of Medicine
University of California San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA
......
In summary, these two studies provide
compelling evidence that immunotherapy
is no longer the future of cancer
treatment, but is very much a current
reality.
The articles by Brahmer et al.
(2012) and Topalian et al. (2012) provide
critical insights into how further understanding
of the basis of cancer immunology will lead to
advances that benefit our patients
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News